Microalbuminuria in essential hypertension: A single centre study

---

Original Article

Author Details : Swati Patel*, Poonam Savlani

Volume : 6, Issue : 3, Year : 2021

Article Page : 189-193

https://doi.org/10.18231/j.jdpo.2021.041

Suggest article by email

Get Permission

---

Abstract

Background: To evaluate the prevalence of microalbuminuria in patients with essential hypertension and its relationship to severity of hypertension, to renal function and its association with coronary artery disease and target organ damage, present study was conducted.
Materials and Methods: Total 100 primary hypertensive, non diabetic patients and 25 healthy normotensive, non diabetic patients (controls) admitted in S.S.G.H (Sir Sayajirao General Hospital) from June 2009 to November 2011. Patient's complete history, routine investigation along with microalbuminuria was measured by ACR by immunoturbidimetric method.
Results: In present study patient’s mean age was 52.7 years. Total 70% of patients selected for study were males and 30% were females. Total 50% to 75% of patients in the 61 -80 year age group were positive for microalbuminuria. Total 42.85% of males were positive for microalbuminuria as compared to 33.33% of females. Total 75% of patients having hypertension for more than 8 years had microalbuminuria. Total 67.5% of patients positive for microalbuminuria had associated target organ damage. Total 45% of patients positive for microalbuminuria had left ventricular hypertrophy and 40% of patients had hypertensive retinopathy.
Conclusion: Microalbuminuria helps to identify incipient nephropathy and vascular changes. Its detection can thus help to prevent the development of complications by aggressive treatment to get down targeting blood pressure.
 

Keywords: Microalbuminuria, Hypertension, Hypertensive Retinopathy, Left Ventricular Hypertrophy.

How to cite : Patel S, Savlani P, Microalbuminuria in essential hypertension: A single centre study. IP J Diagn Pathol Oncol 2021;6(3):189-193

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.